In particular, it was proved that the high levels of MMP-9 in melanoma patients might be due to the dysregulation of the TGFβ pathways where the alterations in the levels of NF-κB is able to induce the overexpression of MMP-9 via OPN activation [34]. The gene discussed is SPP1; the disease is melanoma.